Inclusion Criteria:~* Participant has received a diagnosis of probable Alzheimer Disease (AD) (Diagnostic and
Statistical Manual of Mental Disorders-5 \[DSM-5\]) with the following characteristics at screening: Clinical
Dementia Rating (CDR) global score greater than or equal to (≥) 1; Mini-Mental State Examination (MMSE) total
score of 10 to 24 (inclusive)~* Participant meets the criteria of a syndrome diagnosis of agitation based on
International Psychogeriatric Association (IPA) consensus clinical and research definition of agitation in
cognitive disorders for at least 2 weeks before screening~* Participant meets the criteria of Neuropsychiatric
Inventory (NPI-12) Agitation/Aggression (A/A) domain score ≥ 4 with frequency score ≥ 2 at screening and
baseline with no more than 35 percent (%) of improvement in NPI-12 A/A domain score from the screening to
baseline assessments~* Female participants must be postmenopausal before study entry (amenorrhea for at least
12 months)~* Body Mass Index (BMI) within the range 18-40 kilograms per square meter (kg/m\^2) (inclusive)~
